ESOP23 Sept 2026, 12:24 pm
Jeena Sikho Lifecare gets BSE in-principle approval for ESOS 2024
AI Summary
Jeena Sikho Lifecare Ltd has received in-principle approval from BSE Limited for the listing of up to 6,50,000 equity shares of Rs. 2/- each under its Employees Stock Option Scheme 2024 (ESOS 2024). This follows a similar approval from NSE. The total number of shares approved has been adjusted to 6,50,000 post a stock split from Rs. 10/- to Rs. 2/- face value. The company has now secured approvals from both major stock exchanges for its ESOP scheme.
Key Highlights
- BSE grants in-principle approval for ESOS 2024.
- Up to 6,50,000 equity shares to be listed under the scheme.
- Approval secured from both NSE and BSE.
- Share count adjusted post stock split.
- Scheme aims to incentivize permanent employees.
Price Impact
More from JSLL